One-year clinical and parasitological follow-up of dogs treated with marbofloxacin for canine leishmaniosis. (Q54336184)

28 May 2018

title

One-year clinical and parasitological follow-up of dogs treated with marbofloxacin for canine leishmaniosis. (English)

1 reference

28 May 2018

author name string

Sandrine Rougier

1

1 reference

28 May 2018

Lilia Hasseine

2

1 reference

28 May 2018

Pascal Delaunay

3

1 reference

28 May 2018

Grégory Michel

4

1 reference

28 May 2018

Pierre Marty

5

1 reference

28 May 2018

publication date

12 November 2011

1 reference

28 May 2018

published in

Veterinary Parasitology

1 reference

28 May 2018

volume

186

1 reference

28 May 2018

issue

3-4

1 reference

28 May 2018

page(s)

245-253

1 reference

28 May 2018

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

1 reference

In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Initial and long-term efficacy of a lipid emulsion of amphotericin B desoxycholate in the management of canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Immunomodulatory effects of quinolones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Diagnosis of canine visceral leishmaniasis: biotechnological advances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Decreased sensitivity to meglumine antimoniate (Glucantime) ofLeishmania infantumisolated from dogs after several courses of drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

A simple method for quantifying Leishmania in tissues of infected animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Leishmania DNA load and cytokine expression levels in asymptomatic naturally infected dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Use of the leishmanin skin test and western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in a highly endemic focus in Alpes-Maritimes (France)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Treatment of canine Old World visceral leishmaniasis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naive dogs exposed to three consecutive transmission seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Efficacy of the treatment of dogs with leishmaniosis with a combination of metronidazole and spiramycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

IgG subclass responses in a longitudinal study of canine visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Efficacy of different treatment regimens of marbofloxacin in canine visceral leishmaniosis: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Detection of Leishmania infantum DNA by fret-based real-time PCR in urine from dogs with natural clinical leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Polymerase Chain Reaction Using Noninvasively Obtained Samples, for the Detection ofLeishmania infantumDNA in Dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.11.016

10.1016/J.VETPAR.2011.11.016

7 January 2021

Identifiers

DOI

1 reference

28 May 2018

PubMed ID

22130335

1 reference

28 May 2018